Print Page  Close Window

Investor Relations


Zogenix, Inc. (Nasdaq: ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.
NASDAQ | ZGNX (Common Stock)
$10.50 - 0.1
Stock chart for: ZGNX.O.  Currently trading at $10.50 with a 52 week high of $13.70 and a 52 week low of $7.33.
Data as of 02/24/17 4:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.

Latest Presentations

Zogenix February 2017 Investor Presentation
Download Documentation

Recent News More

Zogenix to Participate in the 2017 RBC Capital Markets Healthcare Conference

Read More

Zogenix Announces Initiation of Clinical Efficacy Portion of Study 1504 for ZX008 in Dravet Syndrome

Read More

Investor Events More